Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from SurgePays ( (SURG) ).
On March 18 and March 23, 2026, SurgePays received notices from Nasdaq that it had fallen below the exchange’s $35 million minimum market value of listed securities and the $1.00 minimum bid price requirement. The company has 180 days from each notice to regain compliance, failing which its shares could face delisting, potentially reducing liquidity, limiting access to equity financing, and constraining its ability to offer equity-based incentives.
Around March 23, 2026, SurgePays issued 800,000 restricted common shares at $1.25 per share to CEO and Chairman Brian Cox to retire $1 million of debt under a 2024 consolidated promissory note. The private, non-public offering used a securities law exemption and effectively converted a portion of related-party debt into equity, modestly strengthening the company’s balance sheet while further aligning the chief executive’s interests with shareholders.
The most recent analyst rating on (SURG) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on SurgePays stock, see the SURG Stock Forecast page.
Spark’s Take on SURG Stock
According to Spark, TipRanks’ AI Analyst, SURG is a Neutral.
The score is held down primarily by weak financial performance (large losses, heavy cash burn, and negative equity) and a bearish technical setup. These are only partially offset by positive earnings-call momentum (rapid revenue growth, improving expense discipline, and upbeat guidance), while valuation remains constrained by loss-making results and the equity raise adds dilution/financing risk.
To see Spark’s full report on SURG stock, click here.
More about SurgePays
SurgePays, Inc. is a publicly traded company whose common stock is listed on the Nasdaq Capital Market. The firm finances its operations in part through equity and debt arrangements, including promissory notes and share issuances to executives, reflecting reliance on capital markets access for liquidity and growth.
Average Trading Volume: 239,283
Technical Sentiment Signal: Sell
Current Market Cap: $20.72M
See more insights into SURG stock on TipRanks’ Stock Analysis page.

